DUKE Duke Capital Limited

TIDMDUKE

RNS Number : 3670G

Duke Royalty Limited

26 July 2021

26 July 2021

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

Trading Update

Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to provide the following trading and operational update for its first financial quarter ended 30 June 2021 ("Q1 FY22"), and to provide guidance on trading for the second quarter of the Company's financial year ended 30 September 2021 ("Q2 FY22").

Highlights:

-- Q1 FY22 cash revenue, being cash distributions from Duke's royalty partners and cash gains from sales of equity assets, totalled GBP2.9 million for the quarter which was marginally above management's expectations

-- On a normalised basis, excluding the effects of redemption premiums and/or equity sales, GBP2.9 million represented a record cash revenue quarter for the Company, surpassing the GBP2.8 million generated in Q4 FY20

-- Successful exit of the non-core investment in Berkley Recruitment (Group) Limited, delivering an IRR of 16.0% in April

-- GBP35 million oversubscribed equity placing completed, increasing liquidity to fund the growing pipeline of investment opportunities

-- Diversified and increased its revenue base through a EUR10.0 million investment into a new royalty partner, Fairmed Healthcare AG, a provider of high-quality generic prescription medicines, over-the-counter pharmaceuticals, dermocosmetics and dietary supplements in various EU countries

-- Elected to exercise warrants granted to Duke from the previous royalty agreement with XtremePush ("XP"). Following the exercise, Duke will hold a 2.7% equity stake in the ordinary shares of XP. The exercise was undertaken concurrent with XP's raise of US$33 million in growth capital to accelerate its global expansion.

-- Based on current trading, Duke expects cash revenue for Q2 FY22 to be GBP3.2 million, which would again represent a record normalised cash revenue quarter for the Company

Neil Johnson, CEO of Duke Royalty, said:

"I am delighted to report that the Company delivered record normalised quarterly cash revenue in Q1 FY22, surpassing the previous highs that were generated prior to the destabilising effects of COVID. This performance is testament to both the resilience of our underlying royalty partners but also the hard work that has been invested by Duke's investment team to successfully navigate these economic headwinds.

"Duke's current strong liquidity position, combined with its deep pipeline of late stage deal opportunities, gives me confidence that further deployments will be completed in the short term that will translate into further increases in quarterly cash revenue for the benefit of all shareholders."

***ENDS***

For further information, please visit www.dukeroyalty.com or contact:

 
                         Neil Johnson / Charlie 
                          Cannon Brookes / Hugo 
 Duke Royalty Limited     Evans                                +44 (0) 1481 730 613 
 Cenkos Securities 
  plc                    Stephen Keys / Callum 
  (Nominated Adviser      Davidson / Julian Morse 
  and Joint Broker)       / Michael Johnson                    +44 (0) 207 397 8900 
 Canaccord Genuity       Adam James / Georgina 
  (Joint Broker)          McCooke                              +44 (0) 207 523 8000 
 SEC Newgate (PR)        Elisabeth Cowell/ Richard           + +44 (0) 20 3757 6882 
                          Bicknell/ Megan Kovach       dukeroyalty@secnewgate.co.uk 
 

About Duke Royalty

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TSTFLFSTDFIEFIL

(END) Dow Jones Newswires

July 26, 2021 02:00 ET (06:00 GMT)

Duke Capital (LSE:DUKE)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Duke Capital (LSE:DUKE)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024